Charles Li
Director/Board Member chez EKSO BIONICS HOLDINGS, INC.
Fortune : 37 275 $ au 31/03/2024
Postes actifs de Charles Li
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 11/03/2018 | - |
| Independent Dir/Board Member | 11/03/2018 | - | |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 10/10/2020 | - |
Historique de carrière de Charles Li
Formation de Charles Li
| Harvard University | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Chine | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EKSO BIONICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- Charles Li
- Expérience
